26 . May , 2019 - Sunday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Fosamprenavir Calcium

Big Image Pronouncation: (FOSS-am-PREN-ah-veer KAL-see-uhm)
Class: Protease inhibitor

Trade Names:
- Tablets 700 mg (equivalent to 600 mg amprenavir)

Mechanism of Action


Fosamprenavir is a prodrug of amprenavir that inhibits HIV protease, the enzyme required to form functional proteins in HIV-infected patients.



As fosamprenavir is absorbed, it is rapidly hydrolyzed to amprenavir by enzymes in the gut epithelium. T max is between 1.5 and 4 h. C max is about 4.82 mcg/mL. AUC is approximately 33 mcg•h/mL. C min is approximately 0.35 mcg/mL.


Approximately 90% protein bound, primarily to alpha 1 -acid glycoprotein.


After oral administration, fosamprenavir is rapidly and almost completely hydrolyzed to amprenavir, which is metabolized in the liver by CYP3A4.


Approximately 1% excreted unchanged in the urine. About 14% and 75% (with more than 90% as metabolites) of an administered dose of amprenavir excreted in the urine and feces, respectively. The t ½ is approximately 7.7 h.

Special Populations

Hepatic Function Impairment

Moderate cirrhosis increases AUC, while severe cirrhosis increases AUC and C max . Patients with impaired hepatic function may require dosage reduction.

Indications and Usage

Treatment of HIV infections in combination with other antiretroviral agents.


Coadministration with drugs highly dependent on CYP3A4 for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events (eg, ergot derivatives [eg, ergonovine]), GI motility agent, neuroleptic agent (eg, pimozide), and sedative/hypnotics (eg, midazolam, triazolam); when administered with ritonavir, flecainide and propafenone are contraindicated; hypersensitivity to any component of this product or to amprenavir.

Dosage and Administration

Therapy-Naïve Patients

PO 1,400 mg twice daily without ritonavir; 1,400 mg every day plus 200 mg ritonavir every day; 700 mg twice daily plus ritonavir 100 mg twice daily.

Protease Inhibitor-Experienced Patients

PO 700 mg twice daily plus ritonavir 100 mg twice daily. Once-daily administration of fosamprenavir plus ritonavir is not recommended in protease inhibitor-experienced patients.

Hepatic Impairment

PO In patients with mild or moderate hepatic impairment receiving fosamprenavir without ritonavir reduce dosage to 700 mg twice daily. Do not use in patients with severe hepatic impairment.

General Advice

  • Administer without regard to meals. Administer with food if GI upset occurs.


Store tablets at controlled room temperature (59° to 86°F). Keep tightly capped.

Drug Interactions

Amiodarone, bepridil, systemic lidocaine, quinidine, tricyclic antidepressants (eg, amitriptyline)

Plasma levels of these drugs may be increased, resulting in serious and/or life-threatening drug interactions.

Atorvastatin, benzodiazepines (eg, alprazolam, clorazepate, diazepam, flurazepam), calcium channel blockers (eg, amlodipine, diltiazem, felodipine, isradipine, nicardipine, nifedipine, nimodipine, nisoldipine, verapamil), cyclosporine, itraconazole, ketoconazole, oral contraceptives (eg, ethinyl estradiol/norethindrone), rapamycin, rifamycins (eg, rifabutin), tacrolimus

Plasma levels of these agents may be elevated by fosamprenavir, increasing the risk of adverse reactions.

Carbamazepine, corticosteroids (eg, dexamethasone), efavirenz, histamine H 2 -receptor antagonists (eg, cimetidine), lopinavir/ritonavir combination, nevirapine, phenobarbital, phenytoin, proton pump inhibitors (eg, omeprazole), saquinavir

Amprenavir plasma levels may be reduced, leading to a decrease in virologic response.


May lead to loss of virologic response and possible resistance to delavirdine.

Drugs highly dependent on CYP3A4 for clearance (eg, ergot derivatives [eg, dihydroergotamine, ergotamine, ergonovine, methylergonovine]), GI motility agent, neuroleptic agent (eg, pimozide), and sedative/hypnotics (eg, midazolam and triazolam)

Administration of these agents with fosamprenavir is contraindicated because of the potential for serious and/or life-threatening reactions.

Flecainide, propafenone

These agents are contraindicated when fosamprenavir is administered with ritonavir.

HMG-CoA reductase inhibitors metabolized by CYP3A4 (eg, lovastatin, simvastatin)

Coadministration is not recommended because the risk of myopathy, including rhabdomyolysis, may be increased.

Indinavir, nelfinavir

Amprenavir plasma levels may be elevated, leading to an increase in adverse reactions.


Plasma levels may be reduced by fosamprenavir, resulting in a loss of pharmacologic response.

Phosphodiesterase inhibitors (eg, sildenafil, vardenafil)

Plasma levels may be increased by amprenavir, increasing the risk of side effects.


Because amprenavir plasma levels may be reduced about 90%, avoid coadministration.

St. John's wort ( hypericum perforatum )

Amprenavir plasma concentrations may be reduced by St. John's wort, decreasing the clinical efficacy; may lead to loss of virologic response and possible resistance to fosamprenavir or to the class of protease inhibitors.


Because warfarin concentrations may be altered, monitoring of international normalized ratio is recommended.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Headache (19%); depressive/mood disorders (8%); paresthesia (2%).


Rash (35%); pruritus (7%); Stevens-Johnson syndrome.


Nausea (39%); diarrhea (34%); vomiting (16%); abdominal pain (5%).


Neutropenia (3%); acute hemolytic anemia.

Lab Tests

Increased serum lipase (8%); increased ALT and AST (6%).


Fatigue (10%).



Category C .


HIV-infected mothers should not breast-feed their infants.


Safety and efficacy not established.


Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity.

Hepatic Function

Because patients with impaired hepatic function may require dosage reduction, use with caution.


It is not known what effect fosamprenavir therapy will have on the subsequent administration of protease inhibitors.

Diabetes mellitus/Hyperglycemia

New onset and exacerbation of preexisting diabetes mellitus and hyperglycemia have been reported. Monitor blood sugar in diabetic patient when drug is started or dose is changed.

Fat redistribution

Redistribution and accumulation of body fat have been observed in patients receiving fosamprenavir. A causal relationship has not been established.


Spontaneous bleeding has been reported in patients with hemophilia A and B treated with protease inhibitors.

Sulfa allergy

Because fosamprenavir contains a sulfonamide moiety, use with caution in patients with sulfa allergy.

Patient Information

  • Advise patient to read the patient information leaflet before starting therapy and with each refill.
  • Warn patient that this drug is not to be used by itself but is combined with other antiviral agents and not to change the dose or stop taking any of the antiviral agents unless advised by health care provider.
  • Advise patient to take prescribed dose without regard to meals but to take with food if GI upset occurs.
  • Advise patient that if a dose is missed by more than 4 h, to wait and take the next dose at the regular time. If a dose is missed by less than 4 h, take the missed dose right away and then take the next dose at the regular time. If a dose is skipped, caution patient not to double the dose to catch up but to continue with normal schedule.
  • Instruct patient to report the following symptoms immediately to health care provider: rash; persistent nausea, vomiting, or diarrhea; any unusual symptom.
  • Inform patient that the drug does not completely eliminate HIV virus and therefore does not reduce risk of transmitting HIV to others. Appropriate precautions must still be taken.
  • Advise patient that the drug is not a cure for HIV infection and that illnesses associated with HIV infection (including opportunistic infections) may continue to be acquired. Patients should remain under a physician's care.
  • Instruct diabetic patient to monitor blood glucose more frequently when drug is started or dose is changed and to inform health care provider of significant changes in readings.
  • Caution women using hormonal contraceptives to use alternative contraceptive measures during therapy because hormonal contraceptive effectiveness may be reduced.
  • Advise women to notify health care provider if pregnant, planning to become pregnant, or breastfeeding. Caution HIV-infected mother that breastfeeding can cause HIV infection in the baby.

Recent Drug Updates at DrugIndexOnline:

Albumin Microspheres Sonicated Albumin Microspheres Sonicated
Some commonly used brand names are: In the U.S.— Optison Description The albumin microspheres sonicated (al-BYOO-min mye-kroe-SFEERS SON-i-kay-ted) preparation is an ultrasound contrast agent. Ultrasound contrast agents are used to help provide a clear picture during ultrasound. Ultra more...

Anorex-SR Anorex-SR
Generic Name: phendimetrazine (fen di MEH tra zeen) Brand Names: Adipost, Anorex-SR, Appecon, Bontril PDM, Bontril Slow-Release, Melfiat, Obezine, Phendiet, Plegine, Prelu-2, Statobex What is Anorex-SR (phendimetrazine)? Phendimetrazine is a sympathomimetic amine, which is similar to an more...

Combunox Combunox
Some commonly used brand names are: In the U.S.— Combunox † Not commercially available in Canada. Category Analgesic Description Ibuprofen and oxycodone (eye-byoo-PROE-fen and ox-i-KOE-done) combination is used to relieve pain. Ibuprofen is a nonsteroidal anti-inflammatory more...

Condylox Topical Condylox Topical
Some commonly used brand names are: In the U.S.— Condylox Another commonly used name is podophyllotoxin . Category Antimitotic agent (topical) Description Podofilox (po-do-FIL-ox) is used to remove certain types of warts on the outside skin of the genital areas (penis or vulva). more...

Flovent HFA Flovent HFA
Generic Name: fluticasone inhalation (floo TIK a zone) Brand Names: Flovent, Flovent HFA, Flovent Rotadisk What is Flovent HFA (fluticasone inhalation)? Fluticasone is a steroid. It prevents the release of substances in the body that cause inflammation. Fluticasone inhalation is used to more...

Miconazole Vaginal Miconazole Vaginal
Some commonly used brand names are: In the U.S.— FemCare 2 Femizol-M 4 Femstat 3 1 Gyne-Lotrimin 2 Gyne-Lotrimin Combination Pack 2 Gyne-Lotrimin3 2 Gyne-Lotrimin3 Combination Pack 2 Miconazole-7 4 Monistat 1 6 Monistat 1 Combination Pack 4 Monistat 3 4 Monistat 3 Combination Pack 4 Monis more...

Omnicef Omnicef
Generic Name: Cefdinir Capsules (SEF-di-nir) Brand Name: OmnicefOmnicef is used for:Treating mild to moderate infections caused by certain bacteria. Omnicef is a cephalosporin antibiotic. It works by killing sensitive bacteria. Do NOT use Omnicef if: you are allergic to any ingredient in Omni more...

Privine Drops Privine Drops
Generic Name: Naphazoline Nasal Drops (naf-AZ-oh-leen) Brand Name: PrivinePrivine Drops is used for:Temporarily relieving stuffy nose due to cold, hay fever, or other upper respiratory allergies associated with sinus inflammation. It may also be used for other conditions as determined by your do more...